- Short Report
- Open Access
Capsule deletion via a λ-Red knockout system perturbs biofilm formation and fimbriae expression in Klebsiella pneumoniae MGH 78578
BMC Research Notesvolume 7, Article number: 13 (2014)
Klebsiella pneumoniae is a leading cause of hospital-acquired urinary tract infections and pneumonia worldwide, and is responsible for many cases of pyogenic liver abscess among diabetic patients in Asia. A defining characteristic of this pathogen is the presence of a thick, exterior capsule that has been reported to play a role in biofilm formation and to protect the organism from threats such antibiotics and host immune challenge.
We constructed two knockout mutants of K. pneumoniae to investigate how perturbations to capsule biosynthesis alter the cellular phenotype. In the first mutant, we deleted the entire gene cluster responsible for biosynthesis of the extracellular polysaccharide capsule. In the second mutant, we deleted the capsule export subsystem within this cluster. We find that both knockout mutants have lower amounts of capsule but produce greater amounts of biofilm. Moreover, one of the two mutants abolishes fimbriae expression as well.
These results are expected to provide insight into the interaction between capsule biosynthesis, biofilm formation, and fimbriae expression in this organism.
Klebsiella pneumoniae is a Gram-negative bacterium that is a member of the family Enterobacteriaceae and is closely related phylogenetically to the genera Escherichia, Salmonella, Shigella, and Yersinia. Medically, K. pneumoniae causes a wide range of diseases worldwide such pneumonia, urinary tract infections, and surgical wound infections that primarily afflict immunocompromised patients in hospital settings and long-term care facilities. The number of community-acquired infections caused by K. pneumoniae, however, has increased worldwide over the past several decades. For example, invasive forms of the disease characterized by bacteremic liver abscesses or endophthalmitis that are contracted in the community are endemic in Asia [1–3], especially in Taiwan [4–7], and reports of their occurrence are now emerging in other parts of the world [8, 9]. Infections caused by K. pneumoniae can be difficult to treat since many clinical isolates possess an extensive repertoire of antibiotic resistance genes. Ominously, some strains have now been isolated from different parts of the world that harbor New Delhi metallo-β-lactamase 1 (NDM-1) [10, 11], a gene that confers resistance to carbapenem antibiotics, the last-line treatment option against most K. pneumoniae infections. Compounding the medical threat is the paucity of new antibiotics that are being developed against multi-drug resistant Gram-negative bacteria such as K. pneumoniae.
Despite its close relationship to other enterobacteria, one notable difference between K. pneumoniae and other members of this family is the presence of an extremely thick, hypermucoviscous, extracellular polysaccharide capsule that surrounds this bacterium. At least 77 distinct capsular serotypes have been reported to date , but virulent strains have been predominantly associated with the K1 and K2 serotypes, in particular K1 [12–15]. The genes responsible for biosynthesis of the capsule are normally located in a cluster that is 21 to 30 kb in length and comprise 16 to 25 ORFs . The capsule is believed to be a major virulence determinant by protecting K. pneumoniae from phagocytosis [17–19] and destruction by antimicrobial peptides . Furthermore, the capsule is thought to play a crucial role in biofilm formation, which allows the organism to colonize indwelling medical devices and better survive hostile conditions such as detergents aimed at removing the biofilms, since mutants of K. pneumoniae strain LM21 with disruptions in different genes involved in capsule biosynthesis produce less biofilm . Consistent with these findings, a separate signature-tagged mutagenesis study also identified a mutation in ORF12 of the K. pneumoniae strain 43816 K2 capsule gene cluster that resulted in less biofilm formation . On the other hand, a third study found that a non-encapsulated derivative of K. pneumoniae strain C105 produced greater amounts of biofilm than the parental strain, and correlated this observation to the expression of type 1 fimbriae . A fourth study found that type 3 fimbriae promoted biofilm formation in a strain that still possessed its capsule .
These findings in aggregate highlight the complex interaction between capsule biosynthesis, biofilm formation, and fimbriae expression. Against this backdrop, we investigated the relationship among encapsulation, biofilm formation, and fimbriae expression in K. pneumoniae strain MGH 78578. Significantly, we found that a non-encapsulated mutant produced larger amounts of biofilm as has been reported , but in contrast also found that no fimbriae was required for this phenotype.
Materials and methods
Strains and primers
Klebsiella pneumoniae strain MGH 78578 was purchased from ATCC. All other strains were generated as part of this study (Table 1). All primers for plasmid construction and gene knockouts can be found in Additional file 1.
All experiments were conducted using bacteria grown in LB, low salt LB, or glucose M9 media. Low salt LB consisted of (per liter) 5 g yeast extract, 10 g tryptone, and 5 g NaCl, and was adjusted to pH 8.0 with NaOH. Glucose M9 was composed of the following chemicals (per liter): 6.8 g Na2HPO4; 3 g KH2PO4; 0.5 g NaCl; 1 g NH4Cl; 100 μM CaCl2; 2 mM MgSO4; 2 g dextrose. Stock solutions of CaCl2, MgSO4, and dextrose were filter sterilized through Millipore ExpressPlus 0.22 μm membranes (Millipore, Billerica, MA) and subsequently added individually to autoclaved solutions containing the first four chemicals. Hygromycin (Sigma-Aldrich, St. Louis, MO) and apramycin (Research Products International, Mt. Prospect, IL) were added to the media to final concentrations of 100 μg/ml and 50 μg/ml, respectively, as necessary. Low salt LB and hygromycin are always used together; all other steps use standard LB.
Construction of knockout mutants
The capsule surrounding K. pneumoniae MGH 78578 belongs to the K52 serotype, which has a hexasaccharide repeating unit composed of two rhamnose, one glucose, one glucuronic acid, and two galactose sugars . Measurements of the amount of capsule surrounding wild-type K. pneumoniae MGH 78578 and all the mutants were based on the protocol of Domenico, et al..
For transcriptome profiling, a high-density oligonucleotide tiling array consisting of 379,528 50-mer probes spaced 30 bp apart across the whole K. pneumoniae MGH 78578 genome was custom-designed by NimbleGen (Roche). Total RNA from OD600 ~0.5 cultures were hybridized to the arrays according to the protocol of Qiu, et al. . The normalized probe level information was transformed into expression level data for each gene using the Genbank annotation for K. pneumoniae MGH 78578 (accession number PRJNA57619). Genes were deemed differentially expressed between the two mutants and the wild-type if there was a 2-fold or greater change and they had a p-value less than 0.05. The expression profiling datasets of K. pneumoniae wild-type and capsule deletion mutant (Δcps) have been deposited in the Gene Expression Omnibus (GEO) database and assigned the accession number GSE40011. Three biological replicates of the wild-type, Δcps, and Δwzabc strains were used to generate the array data.
Transmission electron microscopy imaging
The samples were negatively stained with 1% aqueous uranyl acetate and examined on an FEI Tecnai G2 Sphera transmission electron microscope at 200 keV. Images were recorded on a Gatan Ultrascan UHS CCD camera.
Results and discussion
Deletion of the entire capsule biosynthesis cluster and the export subsystem leads to phenotypic defects in the two mutants
We developed a gene knockout procedure for K. pneumoniae that is based on the widely-used E. coli λ-Red recombinase system. The independent development of a similar protocol was recently reported . The method developed here requires two selection markers, one (apramycin resistance) is used to replace the target gene and the other (hygromycin resistance) selects for two plasmids used at different times to mediate homologous recombination and excision of the apramycin resistance cassette.
We examined how different homology lengths affect transformation efficiency by deleting the same locus in K. pneumoniae using cassettes that contained 39-bp, 60-bp, and 700-bp homology to the target region. This target region was the three genes (wza, wzb, and wzc) that function in capsule export. A total of one microgram of each of the three PCR products was electroporated into the host. We recovered 26, 46, and 255 apramycin-resistant transformants using the 39-bp, 60-bp, and 700-bp homology lengths, resulting in transformation efficiencies of 1.3 × 10-8, 2.5 × 10-8, and 1.1 × 10-7, respectively. To confirm these mutant candidates, we next examined 24 colonies from each group by PCR. None of the 24 colonies from the 39-bp group was a correct knockout mutant, whereas two colonies from the 60-bp group and ten colonies from the 700-bp group were correct (data not shown). Although longer homology lengths resulted in higher transformation efficiency, these results implied that replacement cassettes containing 60-bp homology were sufficient to create knockout mutants. The construction of such cassettes requires DNA oligos that are only 80–85 nucleotides long, which can be readily purchased from commercial vendors. The use of knockout cassettes bearing longer homology arms would require an additional cloning step. For these reasons, we constructed all knockout mutants in this study using 60-bp homology.
We deployed our knockout protocol to investigate how the deletion of genes involved in biosynthesis of the thick, extracellular polysaccharide capsule surrounding K. pneumoniae perturbs the bacterium. We constructed two knockout mutants (Figure 1): the entire capsule biosynthesis cluster was deleted in one mutant, Δcps, whereas three genes responsible for capsule export (the wza-b-c operon) were deleted in the other mutant, Δwzabc (Table 1) [32, 33]. Both deletions are marker-free, and we confirmed that the wild-type allele was completely absent in the two mutants by PCR and Sanger sequencing (Figure 1B).
The growth rates of the wild-type and Δcps strains during batch culture in glucose M9 were 1.022 ± 0.0028 and 0.808 ± 0.0057 (1/hour), respectively, indicating a statistically significant decrease in the growth rate (P < 5 × 10-6, Student’s t-test) (Figure 2A). Growth rates were calculated from time-course OD600 measurements. The Δwzabc mutant showed a biphasic growth pattern in which the growth rate during the first four hours was identical to that of the wild-type (1.026 ± 0.048 1/hour) but dropped to 0.49 ± 0.010 (1/hour) thereafter (Figure 2A).
The quantity of uronic acid that can be extracted from cells provides an indirect measure of the amount of extracellular capsule [34–37]. When compared to wild-type levels, the quantity of uronic acid in the Δcps and Δwzabc mutants declined to 0.29 ± 0.17 and 0.38 ± 0.04 fold change, respectively (P < 7.5 × 10-4 for both, Student’s t-test) (Figure 2B). As a negative control, we performed the same assay side-by-side using blank media only. Absorbance measurements for these control samples were consistently below the detection threshold of our spectrophotometer.
We next measured the sensitivity of the wild-type, Δcps, and Δwzabc strains to oxidative stress and the antimicrobial peptide polymyxin B since the absence of capsule was expected to increase sensitivity to these two stresses. Both measurements were carried out using a disc diffusion assay in which hydrogen peroxide or polymyxin B was impregnated into the disc and then placed onto agar plates covered by a lawn of each strain. The diameter of the inhibition zone of the wild-type and Δwzabc mutant to hydrogen peroxide was 22.3 mm in contrast to 26.7 mm for the Δcps mutant (P < 0.001, Student’s t-test) (Figure 2C). Similarly, the antimicrobial peptide polymyxin B assay produced a diameter of 19.0 mm each time when three independent tests on Δcps were performed, but only 14 mm on wild-type and Δwzabc (Figure 2C).
Expression profiling of the Δcps and Δwzabc deletion mutants reveals interplay between capsule biosynthesis and phenotypic defects
The phenotypic changes we observed in the Δcps capsule deletion mutant motivated us to examine gene expression differences between the Δcps and Δwzabc mutants versus the wild-type strain. Of 112 genes up-regulated more than two-fold (Table 2), those with the greatest fold increase belonged to the gene cluster KPN_04512 – KPN_04515, which is annotated as the pga operon that is responsible for synthesis of poly-beta-1,6-N-acetyl-D-glucosamine (PGA or poly-GlcNAc), a secreted, extracellular component of the biofilm matrix . The transcription level of the pga operon was also slightly elevated in the Δwzabc mutant (Additional file 3).
Eighty-nine genes were down-regulated more than two-fold in the Δcps mutant and fell within several groups: 17 plasmid-borne genes from pKPN3 and pKPN4, 13 metabolic genes, 11 tRNA genes, and eight genes associated with type 1 and type 3 fimbriae. Of the eight fimbriae-associated genes, five were located within the same cluster (KPN_03274 – KPN_03278) (Additional file 3). Genbank currently does not associate this set of genes with a specific type of fimbriae; however, each one is 100% homologous at the amino acid level to the mrk JFDCB cluster from K. pneumoniae NTUH-2044 that encodes type 3 fimbriae. We therefore assume that this set of five genes encodes type 3 fimbriae in K. pneumoniae MGH 78578 as well. The other three (fimA, fimI, and fimC; KPN_03287 – KPN_03289) (Additional file 3) are located within a cluster whose gene product is annotated to be type 1 fimbriae.
Fimbriae biosynthesis is abolished in Δcps but not Δwzabc
In lieu of standard RT-PCR, we interrogated the findings from expression analysis through a series of corresponding phenotypic assays. The down-regulation of genes encoding both type 1 (fim cluster) and type 3 (mrk cluster) fimbriae raised the possibility that fimbriation had declined in the two mutants. To investigate this possibility, we visualized the surface structure of the wild-type and the two knockout mutants using transmission electron microscopy (TEM). Fimbriae could be detected on the surface of the wild-type and Δwzabc mutant but not on the Δcps mutant (Figure 3).
Up-regulation of the pga operon appears to be a more important factor in biofilm formation than down-regulation of the fimbriae-associated operons
Type 1 fimbriae has been previously linked to increased biofilm formation in a non-encapsulated K. pneumoniae mutant . In our non-encapsulated Δcps mutant, however, we observed twice as much biofilm relative to wild-type levels (Figure 4) but no fimbriae (Figure 3) when using a crystal violet assay to quantify the amount of biofilm . These observations suggest that upregulation of the pga operon alone is sufficient to promote biofilm formation in non-encapsulated mutants; fimbriae are not needed. The Δwzabc mutant produced even greater amounts of biofilm (four-fold increase) when compared to the wild-type (Figure 4), but the pga operon was overexpressed only 1.7-fold (Additional file 3). The continued presence of fimbriae suggests that, in this mutant, both the pga operon and fimbriae probably act synergistically to promote biofilm.
In this study, we observed a complex interplay among encapsulation, biofilm formation, and fimbriae expression in Klebsiella pneumoniae MGH 78578. This strain exhibited increased biofilm formation despite the absence of capsule, an effect likely stemming from strong up-regulation of the pga operon. In contrast, other strains with different deletions within the capsule biosynthesis cluster have been reported to produce less biofilm, not more [21, 22, 40]. It is not known, however, how expression levels of the pga operon might have changed in these other mutants. In addition, type 1 fimbriae have been reported to play an important role in biofilm formation in a non-encapsulated K. pneumoniae mutant , but no fimbriae was necessary for increased biofilm formation in the non-encapsulated mutant we generated (Figure 3). Taken together, these observations suggest that overlapping regulatory mechanisms likely act to regulate these three features in K. pneumoniae in a strain-specific manner.
Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, Eom JS, Kim JS, Choi YH, Lee JS, Chung MH, et al: Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infection. 2007, 54: 578-583. 10.1016/j.jinf.2006.11.008.
Kohayagawa Y, Nakao K, Ushita M, Niino N, Koshizaki M, Yamamori Y, Tokuyasu Y, Fukushima H: Pyogenic liver abscess caused by Klebsiella pneumoniae genetic serotype K1 in Japan. J Infect Chemother. 2009, 15: 248-251. 10.1007/s10156-009-0695-7.
Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, Koh TH, Ip M: Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol. 2011, 49: 3761-3765. 10.1128/JCM.00977-11.
Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC: Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis. 2007, 45: 284-293. 10.1086/519262.
Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, Siu LK: A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?. Gut. 2002, 50: 420-424. 10.1136/gut.50.3.420.
Tsai FC, Huang YT, Chang LY, Wang JT: Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. 2008, 14: 1592-1600. 10.3201/eid1410.071254.
Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wann SR, Lin HH: Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 1998, 26: 1434-1438. 10.1086/516369.
Abate G, Koh TH, Gardner M, Siu LK: Clinical and bacteriological characteristics of Klebsiella pneumoniae causing liver abscess with less frequently observed multi-locus sequences type, ST163, from Singapore and Missouri, US. J Microbiol Immunol. 2012, 45: 31-36. 10.1016/j.jmii.2011.09.002.
Pope JV, Teich DL, Clardy P, McGillicuddy DC: Klebsiella pneumoniae liver abscess: an emerging problem in North America. J Emerg Med. 2011, 41: e103-e105. 10.1016/j.jemermed.2008.04.041.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, et al: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010, 10: 597-602. 10.1016/S1473-3099(10)70143-2.
Moellering RC: NDM-1–a cause for worldwide concern. New Engl J Med. 2010, 363: 2377-2379. 10.1056/NEJMp1011715.
Podschun R, Ullmann U: Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998, 11: 589-603.
Fresno S, Jimenez N, Izquierdo L, Merino S, Corsaro MM, De Castro C, Parrilli M, Naldi T, Regue M, Tomas JM: The ionic interaction of Klebsiella pneumoniae K2 capsule and core lipopolysaccharide. Microbiology. 2006, 152: 1807-1818. 10.1099/mic.0.28611-0.
Mizuta K, Ohta M, Mori M, Hasegawa T, Nakashima I, Kato N: Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect Immun. 1983, 40: 56-61.
Wu KM, Li LH, Yan JJ, Tsao N, Liao TL, Tsai HC, Fung CP, Chen HJ, Liu YM, Wang JT, et al: Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol. 2009, 191: 4492-4501. 10.1128/JB.00315-09.
Shu HY, Fung CP, Liu YM, Wu KM, Chen YT, Li LH, Liu TT, Kirby R, Tsai SF: Genetic diversity of capsular polysaccharide biosynthesis in Klebsiella pneumoniae clinical isolates. Microbiology. 2009, 155: 4170-4183. 10.1099/mic.0.029017-0.
Domenico P, Salo RJ, Cross AS, Cunha BA: Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect Immun. 1994, 62: 4495-4499.
Evrard B, Balestrino D, Dosgilbert A, Bouya-Gachancard JL, Charbonnel N, Forestier C, Tridon A: Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun. 2010, 78: 210-219. 10.1128/IAI.00864-09.
Lawlor MS, Hsu J, Rick PD, Miller VL: Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol. 2005, 58: 1054-1073. 10.1111/j.1365-2958.2005.04918.x.
Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA: Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun. 2004, 72: 7107-7114. 10.1128/IAI.72.12.7107-7114.2004.
Balestrino D, Ghigo JM, Charbonnel N, Haagensen JA, Forestier C: The characterization of functions involved in the establishment and maturation of Klebsiella pneumoniae in vitro biofilm reveals dual roles for surface exopolysaccharides. Environ Microbiol. 2008, 10: 685-701. 10.1111/j.1462-2920.2007.01491.x.
Boddicker JD, Anderson RA, Jagnow J, Clegg S: Signature-tagged mutagenesis of Klebsiella pneumoniae to identify genes that influence biofilm formation on extracellular matrix material. Infect Immun. 2006, 74: 4590-4597. 10.1128/IAI.00129-06.
Schembri MA, Blom J, Krogfelt KA, Klemm P: Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun. 2005, 73: 4626-4633. 10.1128/IAI.73.8.4626-4633.2005.
Schroll C, Barken KB, Krogfelt KA, Struve C: Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol. 2010, 10: 179-10.1186/1471-2180-10-179.
Herring CD, Glasner JD, Blattner FR: Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli. Gene. 2003, 311: 153-163.
Cherepanov PP, Wackernagel W: Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene. 1995, 158: 9-14. 10.1016/0378-1119(95)00193-A.
Gust B, Challis GL, Fowler K, Kieser T, Chater KF: PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc Natl Acad Sci USA. 2003, 100: 1541-1546. 10.1073/pnas.0337542100.
Wei D, Wang M, Shi J, Hao J: Red recombinase assisted gene replacement in Klebsiella pneumoniae. J Ind Microbiol Biotechnol. 2012, 39: 1219-1226. 10.1007/s10295-012-1117-x.
Stenutz R, Erbing B, Widmalm G, Jansson PE, Nimmich W: The structure of the capsular polysaccharide from Klebsiella type 52, using the computerised approach CASPER and NMR spectroscopy. Carbohyd Res. 1997, 302: 79-84. 10.1016/S0008-6215(97)00106-7.
Domenico P, Schwartz S, Cunha BA: Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun. 1989, 57: 3778-3782.
Qiu Y, Cho BK, Park YS, Lovley D, Palsson BO, Zengler K: Structural and operational complexity of the Geobacter sulfurreducens genome. Genome Res. 2010, 20: 1304-1311. 10.1101/gr.107540.110.
Dong C, Beis K, Nesper J, Brunkan-Lamontagne AL, Clarke BR, Whitfield C, Naismith JH: Wza the translocon for E. coli capsular polysaccharides defines a new class of membrane protein. Nature. 2006, 444: 226-229. 10.1038/nature05267.
Whitfield C: Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem. 2006, 75: 39-68. 10.1146/annurev.biochem.75.103004.142545.
Dutton GG, Lim AV: Structural investigation of the capsular polysaccharide of Klebsiella serotype K35. Carbohyd Res. 1985, 145: 67-80. 10.1016/S0008-6215(00)90413-0.
Dutton GG, Paulin M: Structure of the capsular polysaccharide of Klebsiella serotype K53. Carbohyd Res. 1980, 87: 107-117. 10.1016/S0008-6215(00)85195-2.
Joseleau JP: Structural investigation of the capsular polysaccharide of Klebsiella serotype K 49. Carbohyd Res. 1985, 142: 85-92. 10.1016/S0008-6215(00)90735-3.
Nath K, Chakraborty AK: Studies of the primary structure of the capsular polysaccharide from Klebsiella serotype K15. Carbohyd Res. 1987, 161: 91-96. 10.1016/0008-6215(87)84008-9.
Wang X, Preston JF, Romeo T: The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol. 2004, 186: 2724-2734. 10.1128/JB.186.9.2724-2734.2004.
Huang YJ, Liao HW, Wu CC, Peng HL: MrkF is a component of type 3 fimbriae in Klebsiella pneumoniae. Res Microbiol. 2009, 160: 71-79. 10.1016/j.resmic.2008.10.009.
Wu MC, Lin TL, Hsieh PF, Yang HC, Wang JT: Isolation of genes involved in biofilm formation of a Klebsiella pneumoniae strain causing pyogenic liver abscess. PLoS One. 2011, 6: e23500-10.1371/journal.pone.0023500.
This study was funded from a grant from the National Health Research Institutes of Taiwan through PH-099-SP-10. We acknowledge the use of the UCSD Cryo-Electron Microscopy Facility which is supported by NIH grants to Dr. Timothy S. Baker and a gift from the Agouron Institute to UCSD. We thank Jay Sung-Joong Hong and Yu Qiu for helpful discussion on microarray experiments. We thank Nicole Fong and Valerie Khaw for technical assistance. We thank Dr. Frederick R. Blattner at the University of Wisconsin-Madison for kindly sharing the pACBSR plasmid and Dr. Carton W. Chen at National Yang-Ming University for kindly sharing the pIJ773 plasmid.
The authors declare that they have no competing interests.
TWH, IL, and PC carried out the experiments. TWH, HYC, SFT, BOP, and PC designed the study. All authors participated in manuscript preparation. All authors have read and approved the final manuscript.
Electronic supplementary material
About this article
- Klebsiella pneumoniae
- Expression profiling
- Gene knockouts
- Transmission electron microscopy
- Infectious disease